Paul L. Swiecicki1 article listing Paul L. Swiecicki in Nature Communications, indexed by Paperzzz from Crossref and OSF.MDM2 Inhibition with Alrizomadlin (APG-115) in TP53 wild-type salivary gland cancers: a phase I clinical trial Nature Communications